do glp 1 affect bipolar disorder GLP-1 medications continue to surprise researchers with benefits that may go beyond weight management. New research suggests they may be linked to lower odds of depression and disorder, highlighting the connection The risk of depression, anxiety,

CJC 1295 mimics natural GHRH, keeping GH levels steady over timeespecially with the DAC version, which extends its half-life

Riddle MC, Forst T, Aronson R, Sauque-Reyna L, Souhami E, Silvestre L, et al

2023: Lawsuits are filed against Novo Nordisk on behalf of patients who took the drugs and developed gastroparesis/stomach paralysis problems Pop Culture Weight Loss Phenomenon Is Paralyzing Peoples Stomachs FDA, Scientific Studies and Literature on Ozempic, Wegovy, and Rybelsus Gastroparesis/Stomach Paralysis The below studies constitute a small sampling of the scientific literature and studies published on the diabetes weight-loss drugs and gastroparesis/stomach paralysis: Jensterle et al (2023) : Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity This was a small clinical trial of 20 obese female patients with polycystic ovary syndrome who were given semaglutide or placebo

Improved Energy Levels: One of the primary benefits reported by individuals who undergo Myers Cocktail IV therapy is increased energy levels